According to the research report, the global celland gene therapy market size is expected to touch USD 93.78 Billion by 2030, from USD 18.61 Billion in 2022, growing with a significant CAGR of 22.41% from 2022 to 2030.
The cell and gene therapy market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global cell and gene therapy market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global cell and gene therapy market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global cell and gene therapy market during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/2445
| Report Coverage | Details |
| Market Size in 2022 | USD 18.61 Billion |
| Market Size by 2030 | USD 93.78 Billion |
| CAGR | 22.41% From 2022 to 2030 |
| Gene Therapy Segment Market Share | 52% in 2022 |
| North America Market Share | 48% in 2022 |
| Base Year | 2022 |
| Segments Covered | Therapy Type, Therapeutic class, End User, Delivery Method, Region |
This study covers a detailed segmentation
of the global cell and gene therapy market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global cell and gene therapy market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- Alnylam Pharmaceuticals Inc.
- Amgen Inc.
- Biogen Inc.
- CORESTEM Inc.
- Dendreon Pharmaceuticals LLC.
- Helixmith Co. Ltd.
- JCR Pharmaceuticals Co. Ltd.
- Kolon TissueGene Inc.
- Novartis AG
- Pfizer Inc.
Market Segmentation
- Cell Therapy
- Stem Cells
- T Cells
- Dendritic Cells
- NK Cells
- Tumor Cells
- Gene Therapy
By Therapeutic class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
By Delivery Method
- In Vivo
- Ex vivo
By End-Users
- Hospitals
- Cancer Care Centers
- Wound Care Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Research Methodology
The research methodology adopted by
analysts for compiling the global cell and gene therapy market report is based
on detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global cell and gene therapy market.
TABLE OF CONTENT
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments